MUMBAI, India, June 27 -- Intellectual Property India has published a patent application (202517055417 A) filed by Universitat De Barcelona; Universidad De Granada; and Universita Degli Studi Di Catania, Barcelona, Spain, on June 9, for 'dual inhibitors of sigma-1 receptor and soluble epoxide hydrolase and their use in the treatment of pain.'
Inventor(s) include Vazquez Cruz, Santiago; Pujol Bech, Eugenia-Alexandra; Sanchez Sanchez-Corral, Javier; Escriche Molina, Celia; Cobos Del Moral, Enrique Jose; Entrena Fernandez, Jose Manuel; Ruiz Cantero, Maria Del Carmen; Amata, Emanuele; and Dichiara, Maria.
The application for the patent was published on June 27, under issue no. 26/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides compounds of formula (I) for use in the treatment or prevention of pain. The present invention further provides compounds of formula (I') or (Ibis), as well as pharmaceutical composition comprising thereof. Advantageously, the compounds of formula (I), (I') and (Ibis) show a dual effect, inhibiting the soluble epoxide hydrolase and binding to S1 receptor, two of the targets well-documented as involved in pain."
The patent application was internationally filed on Nov. 17, 2023, under International application No.PCT/EP2023/082202.
Disclaimer: Curated by HT Syndication.
